|
C8ORF39 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.35899982775823E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.3644999987188E-08 |
| Normal-vs-Stage2 |
6.822100E-04 |
| Normal-vs-Stage3 |
1.402660E-04 |
| Normal-vs-Stage4 |
1.032090E-04 |
| Stage1-vs-Stage2 |
5.014200E-01 |
| Stage1-vs-Stage3 |
8.418400E-01 |
| Stage1-vs-Stage4 |
7.954600E-01 |
| Stage2-vs-Stage3 |
4.727200E-01 |
| Stage2-vs-Stage4 |
6.999400E-01 |
| Stage3-vs-Stage4 |
7.057000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.34440000745906E-09 |
| Normal-vs-AfricanAmerican |
2.141400E-03 |
| Normal-vs-Asian |
9.386000E-02 |
| Caucasian-vs-AfricanAmerican |
9.933600E-01 |
| Caucasian-vs-Asian |
1.614790E-01 |
| AfricanAmerican-vs-Asian |
1.956780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.85139999681661E-08 |
| Normal-vs-Female |
7.57139995144485E-09 |
| Male-vs-Female |
3.655800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.059600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.32790003834782E-09 |
| Normal-vs-Age(61-80Yrs) |
1.18510000002292E-06 |
| Normal-vs-Age(81-100Yrs) |
5.169800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.771800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.643800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.344400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.985760E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.769000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.067000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.019600E-02 |
| Normal-vs-Grade 2 |
2.36190000002523E-07 |
| Normal-vs-Grade 3 |
7.16800000466478E-08 |
| Normal-vs-Grade 4 |
7.541500E-03 |
| Grade 1-vs-Grade 2 |
6.338300E-02 |
| Grade 1-vs-Grade 3 |
8.965600E-02 |
| Grade 1-vs-Grade 4 |
3.609900E-02 |
| Grade 2-vs-Grade 3 |
6.893000E-01 |
| Grade 2-vs-Grade 4 |
4.010000E-01 |
| Grade 3-vs-Grade 4 |
2.664400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.34350000411143E-08 |
| Normal-vs-ccB subtype |
2.7790000000083E-06 |
| ccA subtype-vs-ccB subtype |
9.968600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.9247000094278E-09 |
| Normal-vs-N1 |
4.946000E-01 |
| N0-vs-N1 |
1.977050E-01 |
|
|
